Metabometrix Ltd
Data not obtained from trial balance AutoHide is on
Enter data in the white spaces Enter numbers as + unless indicated Current year Comparative
Units (eg £ or £000) £ include a trailing space
Company registration number 03982959
Date
Approval date of the accounts by the board 15/10/2023
Date
Date of signing on the audit/accountants report 15/10/2023
Date of engagement letter (required for Date
CA and ACCA reports)
Person signing directors' report:
Name of director Prof J Lindon
Or, name of secretary
Name of director signing balance sheet Prof J Lindon
Address of registered office:
Address line 1 12 Lodgefield
Address line 2 Welwyn Garden City
City or town Hertfordshire
County or region
Postcode AL7 1SD
Name of senior statutory auditor
Name of auditors/accountants James Mercy & Co
Type of firm (eg Chartered Accountants) Chartered Certified Accountants
Address of auditors/accountants
Address line 1 18 Dale View Crescent
Address line 2 Chingford
City or town London
County or region
Postcode E4 6PQ
Prior year adjustments (+ for a gain; - for a loss) £
Correction of prior year errors
Effect of retrospective changes in accounting policies
More info on prior year adjustments
Number Number
Average number of persons employed by the company 0 0
Freehold land & buildings if
revalued amounts shown in trial balance: £ £
historical cost
cumulative depreciation based on cost
Historical cost of fixed asset investments £ £
Investments in subsidiaries
Other investments
£ £
Amounts due after more than one year included in debtors
Amounts included in creditors falling due for payment
after more than five years: £ £
Payable otherwise than by installment
Payable by installment
£ £
Secured bank loans included in creditors
Capital commitments: £ £
contracted
Total future payments due under non-cancellable £ £
operating leases
Registered number
03982959
Metabometrix Ltd
Filleted Accounts
31 January 2023
Metabometrix Ltd
Registered number: 03982959
Balance Sheet
as at 31 January 2023
Notes 2023 2022
£ £
Current assets
Cash at bank and in hand 5,351 4,344
Creditors: amounts falling due within one year 3 (217,802) (216,782)
Net current liabilities (212,451) (212,438)
Total assets less current liabilities (212,451) (212,438)
Creditors: amounts falling due after more than one year 4 (336,978) (356,978)
Net liabilities (549,429) (569,416)
Capital and reserves
Called up share capital 1,426 1,426
Share premium 1,400,945 1,400,945
Revaluation reserve 5 9,586 9,586
Profit and loss account (1,961,386) (1,981,373)
Shareholders' funds (549,429) (569,416)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Prof J Lindon
Director
Approved by the board on 15 October 2023
Metabometrix Ltd
Notes to the Accounts
for the year ended 31 January 2023
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Freehold buildings over 50 years
Leasehold land and buildings over the lease term
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 February 2022 675,000
At 31 January 2023 675,000
Depreciation
At 1 February 2022 675,000
At 31 January 2023 675,000
Net book value
At 31 January 2023 -
3 Creditors: amounts falling due within one year 2023 2022
£ £
Bank loans and overdrafts 150 130
Trade creditors 16,586 16,586
Taxation and social security costs 1,236 1,236
Other creditors 199,830 198,830
217,802 216,782
4 Creditors: amounts falling due after one year 2023 2022
£ £
Obligations under finance lease and hire purchase contracts (20,000) -
Convertible debentures 356,978 356,978
336,978 356,978
5 Revaluation reserve 2023 2022
£ £
At 1 February 2022 9,586 9,586
At 31 January 2023 9,586 9,586
6 Other information
Metabometrix Ltd is a private company limited by shares and incorporated in England. Its registered office is:
12 Lodgefield
Welwyn Garden City
Hertfordshire
AL7 1SD
Metabometrix Ltd 03982959 false 2022-02-01 2023-01-31 2023-01-31 VT Final Accounts April 2022 Prof J Lindon No description of principal activity 03982959 2021-02-01 2022-01-31 03982959 core:WithinOneYear 2022-01-31 03982959 core:AfterOneYear 2022-01-31 03982959 core:ShareCapital 2022-01-31 03982959 core:SharePremium 2022-01-31 03982959 core:OtherReservesSubtotal 2022-01-31 03982959 core:RetainedEarningsAccumulatedLosses 2022-01-31 03982959 core:RevaluationReserve 2021-01-31 03982959 2022-02-01 2023-01-31 03982959 bus:PrivateLimitedCompanyLtd 2022-02-01 2023-01-31 03982959 bus:AuditExempt-NoAccountantsReport 2022-02-01 2023-01-31 03982959 bus:Director40 2022-02-01 2023-01-31 03982959 1 2022-02-01 2023-01-31 03982959 2 2022-02-01 2023-01-31 03982959 countries:England 2022-02-01 2023-01-31 03982959 bus:FRS102 2022-02-01 2023-01-31 03982959 bus:FullAccounts 2022-02-01 2023-01-31 03982959 2023-01-31 03982959 core:WithinOneYear 2023-01-31 03982959 core:AfterOneYear 2023-01-31 03982959 core:ShareCapital 2023-01-31 03982959 core:SharePremium 2023-01-31 03982959 core:OtherReservesSubtotal 2023-01-31 03982959 core:RetainedEarningsAccumulatedLosses 2023-01-31 03982959 core:PlantMachinery 2023-01-31 03982959 core:RevaluationReserve 2023-01-31 03982959 2022-01-31 03982959 core:PlantMachinery 2022-01-31 03982959 core:RevaluationReserve 2022-01-31 iso4217:GBP xbrli:pure